EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Killer Ig-like Receptors in Diseases from A to Z

Luisa Agnello, Anna Masucci, Martina Tamburello, Roberta Vassallo, Davide Massa, Rosaria Vincenza Giglio, Mauro Midiri, Caterina Maria Gambino, Marcello Ciaccio iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073242 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Luisa Agnello und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Biochemistry, Clinical Molecular Medicine, and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advan…. Hauptthemen laut MEDLINE: Receptors, KIR, Neoplasms, Autoimmune Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 406 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Killer Ig-like Receptors (KIRs) regulate immune responses, maintaining the balance between activation and inhibition of the immune system. KIRs are expressed on natural killer cells and some CD8 T cells and interact with HLA class I molecules, influencing various physiological and pathological processes. KIRs’ polymorphism creates a variability in immune responses among individuals. KIRs are involved in autoimmune disorders, cancer, infections, neurological diseases, and other diseases. Specific combinations of KIRs and HLA are linked to several diseases’ susceptibility, progression, and outcomes. In particular, the balance between inhibitory and activating KIRs can determine how the immune system responds to pathogens and tumors. An imbalance can lead to an excessive response, contributing to autoimmune diseases, or an inadequate response, allowing immune evasion by pathogens or cancer cells. The increasing number of studies on KIRs highlights their essential role as diagnostic and prognostic biomarkers and potential therapeutic targets. This review provides a comprehensive overview of the role of KIRs in all clinical conditions and diseases, listed alphabetically, where they are analyzed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, KIRNeoplasmsAutoimmune DiseasesHumansKiller Cells, NaturalAnimalsPolymorphism, Genetic

Stichwörter der Autor:innen

KIRautoimmune diseasesgeneticpolymorphisms

Substanzen

Receptors, KIR

Autor:innen und Institutionen

  • Institute of Clinical Biochemistry, Clinical Molecular Medicine, and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90133 Palermo, Italy.
  • Department of Laboratory Medicine, University Hospital "P. Giaccone", 90127 Palermo, Italy.
  • Institute of Legal Medicine, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90133 Palermo, Italy.

ORCID-Profile: Marcello Ciaccio

Zitieren

APA

Agnello, L., Masucci, A., Tamburello, M., Vassallo, R., Massa, D., Giglio, R. V., Midiri, M., Gambino, C. M., & Ciaccio, M. (2025). The Role of Killer Ig-like Receptors in Diseases from A to Z. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073242

Vancouver

Agnello L, Masucci A, Tamburello M, Vassallo R, Massa D, Giglio RV, et al. The Role of Killer Ig-like Receptors in Diseases from A to Z. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073242

BibTeX
@article{Agnello2025,
  author = {Agnello, Luisa and Masucci, Anna and Tamburello, Martina and Vassallo, Roberta and Massa, Davide and Giglio, Rosaria Vincenza and Midiri, Mauro and Gambino, Caterina Maria and Ciaccio, Marcello},
  title = {The Role of Killer Ig-like Receptors in Diseases from A to Z},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073242}
}
Kostenlos starten →